Nuvalent (NUVL) 10-Q2024 Q1 Quarterly report

Filed: 9 May 24, 6:46am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. senior Avg

New words: AACR, adult, apparent, arbitrage, arbitrarily, arbitrary, argument, artificial, AstraZeneca, awaiting, bad, barred, bearing, Bio, BIOSECURE, calculated, Canadian, capriciously, certiorari, climate, constitutionality, Council, cultural, Dakota, destined, disaggregated, dismissed, ensartinib, equipment, fundamentally, gathering, heard, infeasible, instruction, intelligence, intrinsic, invoicing, Janssen, largest, led, mifepristone, missing, misuse, mutant, navigate, nonvoting, Nordisk, North, Novo, Nuvation, onboarding, onsite, Parliament, perception, PhRMA, plaintiff, PMA, readily, reconciliation, RSU, scarce, segment, simultaneously, speak, speculative, standing, stay, stayed, sue, theft, timeframe, truthful, unbiased, vendor, Windsor, Wisconsin, writ, Xcovery, zidesamtinib, zongertinib

Removed: accounted, accrual, administrator, Andrew, AnHeart, ASC, asset, assumed, assuming, auditor, authoritative, automatically, Bain, balance, cancelled, closing, component, computed, conferring, corroborated, deducted, deducting, discounted, displayed, dividing, document, earned, electorate, ending, exemption, exit, federally, filer, forfeited, fusion, golden, Hack, handle, HMR, impairment, inclusive, institution, insured, invested, IPO, leaving, left, lesser, liquid, match, matching, maximize, month, Morgan, nominated, nonbinding, obligated, observable, orderly, parachute, percent, Piper, potent, preceding, pretax, procedure, proportion, protracted, provisionally, proxy, reacquired, Realized, refer, restatement, reversal, rotation, salary, Sandler, SI, space, supplement, supported, tested, toxicology, TRK, TRKB, underwriting, unobservable, unrealized, unvested, voted

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

NUVL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Alexandra Balcom, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q of Nuvalent, Inc. for the quarter ended March 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Nuvalent, Inc.


Date: May 9, 2024	By:	/s/ Alexandra Balcom
		Alexandra Balcom
		Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)